RNAC
Cartesian Therapeutics·NASDAQ
--
--(--)
--
--(--)
RNAC fundamentals
Cartesian Therapeutics (RNAC) released its earnings on Aug 7, 2025: revenue was 298.00K (YoY -99.10%), missed estimates; EPS was 0.5 (YoY -7.41%), beat estimates.
Revenue / YoY
298.00K
-99.10%
EPS / YoY
0.5
-7.41%
Report date
Aug 7, 2025
Earnings
EPS
Revenue
Revenue & Expenses
RNAC has released its 2025 Q4 earnings report, with revenue of 947.00K, reflecting a YoY change of 224.77%, and net profit of -92.58M, showing a YoY change of -802.92%. The Sankey diagram below clearly presents RNAC's revenue sources and cost distribution.
Key Indicators
Cartesian Therapeutics (RNAC) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Cartesian Therapeutics (RNAC)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Cartesian Therapeutics (RNAC)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Cartesian Therapeutics (RNAC)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Cartesian Therapeutics (RNAC) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Cartesian Therapeutics (RNAC) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Cartesian Therapeutics's latest dividend and current dividend yield?What is Cartesian Therapeutics's gross profit margin?What is the revenue and EPS growth rate for Cartesian Therapeutics year over year?What guidance did Cartesian Therapeutics's management provide for the next earnings period?What is the market's earnings forecast for Cartesian Therapeutics next quarter?What does Cartesian Therapeutics do and what are its main business segments?What factors drove the changes in Cartesian Therapeutics's revenue and profit?What were the key takeaways from Cartesian Therapeutics's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
